Hironori Okada

Title: Hironori Okada: Innovator in Gene Therapy

Introduction

Hironori Okada is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of gene therapy, particularly through his innovative work on adeno-associated virus (AAV) technology. His research focuses on developing methods for gene transfer that can potentially lead to advancements in medical treatments.

Latest Patents

Hironori Okada holds a patent for a mutant of adeno-associated virus (AAV) capsid protein. This invention includes a mutant that contains at least one amino acid substitution in the PLA2 domain compared to the wild-type AAV capsid protein. The patent encompasses a nucleic acid encoding the mutant, a cell containing the nucleic acid, and a method for producing a recombinant AAV particle. Additionally, it describes a recombinant AAV particle containing the mutant, a composition with the recombinant AAV particle, and a method for transferring a gene into a target cell.

Career Highlights

Throughout his career, Hironori Okada has worked with esteemed institutions such as the Nippon Medical School Foundation and the National Center of Neurology and Psychiatry. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Hironori Okada has collaborated with notable colleagues, including Takashi Okada and Hiromi Kinoh. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective research areas.

Conclusion

Hironori Okada's contributions to gene therapy through his patent on AAV technology highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medical science and gene transfer techniques.